Abstract
Over the past decade, the integration of nanotechnology into medicine, known as nanomedicine, has revolutionized diagnostic and therapeutic techniques, offering potential solutions for currently incurable diseases. Cutting-edge approaches such as gene therapy, the use of nucleic acids as therapeutic agents, and the use of nano systems as shuttles for drug delivery have garnered significant attention in the research community. Some of these nano-therapies have even reached clinical application, transitioning from the realm of specialized experts to benefiting the general public, patients, and their families. However, these advancements have also raised ethical and social concerns, as particularly highlighted by the COVID-19 pandemic, which has evidenced how the introduction of novel medical techniques prompted critical questions surrounding ethics, transparency, and human dignity. The manner in which nanotechnology research and applications are introduced to society, the ethical responsibility of professionals, and the way health and social issues are addressed can greatly impact public trust and the future of medical innovation. This chapter aims to analyze and emphasize the importance of ethics and transparent communication in medical innovation, as well as the crucial role of scientists, researchers, and doctors in understanding their ethical and social responsibilities and the influential power their opinions hold in society. By fostering credible communication, it is possible to shape a fair and transparent progress while mitigating public fear, prejudice, and backlash. Effective and simple communication, along with the utmost respect for the well-being of humans and animals throughout all stages of research development, should shape the future of medicine.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Doxil®, a nanodrug based on a lipid nano-vector containing a chemotherapeutic drug.
- 2.
Theranostics is a term formed by the word “therapeutics” and “diagnosis”. Theranostics systems are nanoscale platforms able to integrate both diagnosis and treatment of a specific pathology.
References
Pautler M, Brenner S (2010) Nanomedicine: promises and challenges for the future of public health. Int J Nanomed 5:803–809
Soares S, Sousa J, Pais A, Vitorino C (2018) Nanomedicine: principles, properties, and regulatory issues. Front Chem 6(360)
Jiang L, Carmichaels KA (2019) Innovating nanoethics. AMA J Ethics® 21(4):313–316
AIFA homepage. https://www.aifa.gov.it/vaccini-covid-19. Last accessed 06 Apr 2023
Huang X, Kong N, Zhang X, Cao Y, Langer R, Tao W (2022) The landscape of mRNA nanomedicine. Nat Med 28:2273–2287
Kazemi A, Majidinia M, Jamali AA (2014) The question of ethics in nanomedicine. J Clinic Res Bioeth 5:193
Resnik DB, Tinkle SS (2007) Ethics in nanomedicine. Nanomedicine (Lond) 2(3):345–350
Van Calster G (2006) Regulating nanotechnology in the European Union. Nanotechnol, Low Bus 3(3):359–372
Ponce Del Catillo AM (2009) Nanos in the human body—medical perspectives and ethical concerns. HesaMag #01
OECD website. https://www.oecd.org/coronavirus/policy-responses/transparency-communication-and-trust-the-role-of-public-communication-in-responding-to-the-wave-of-disinformation-about-the-new-coronavirus-bef7ad6e/. Last accessed 06 Apr 2023
Porat T, Nyrup R, Calvo RA, Paudyal P, Ford E (2020) Public health and risk communication during COVID-19—enhancing psychological needs to promote sustainable behavior change. Front Public Health 8:573397
Emanuel EJ, Upshur REG, Smith MJ (2022) What Covid has taught the world about ethics. N Engl J Med 387(17):1542–1545
Venkatashiva RB, Gupta A (2020) Importance of effective communication during COVID-19 infodemic. J Family Med Prim Care 9:3793–3796
Resnik DB (2015) Bioethical issues in providing financial incentives to research participants. Medicoleg Bioeth 5:35–41
Central University Research Ethics Committee (CUREC). https://researchsupport.admin.ox.ac.uk/files/bpg05paymentsandincentivesinresearchv10pdf. Last accessed 25 Aug 2023
AIRC. https://www.airc.it/cancro/affronta-la-malattia/come-affrontare-la-malattia/studi-clinici. Last accessed 06 Apr 2023
NHS Clinical trials homepage. https://www.nhs.uk/conditions/clinical-trials/. Last accessed 06 Apr 2023
Informed consent—European Commission. https://ec.europa.eu/research/participants/data/ref/fp7/89807/informed-consent_en.pdf. Last accessed 06 Apr 2023
Shah P, Thornton I, Turrin D et al (2022) Informed consent. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL)
Petryna A (2007) Clinical trials offshored: on private sector science and public health. BioSocieties 2:21–40
NIH website. https://www.nia.nih.gov/health/what-are-clinical-trials-and-stu-ies#:~:text=Clinical%20trials%20are%20research%20studies,safe%20and%20effective%20in%20people. Last accessed 06 Apr 2023
Juma C (2016) Innovation and its enemies: why people resist new technologies, 1st edn. Oxford University Press, Oxford; New York
Boddice R (2016) Vaccination, fear and historical relevance. Hist Compass 14(2):71–78
NIH website. https://www.niehs.nih.gov/research/resources/bioethics/whatis/index.cfm. Last accessed 14 June 2023
Steneck NH (2007) Introduction to the responsible conduct of research. Revised edition. https://ori.hhs.gov/sites/default/files/2018-04/rcrintro.pdf
Doemeny L, Knerr P (2017) The importance of ethical conduct in scientific research. American Chemical Society
Sauer MA, Truelove S, Gerste AK, Limaye RJ (2021) A failure to communicate? How public messaging has strained the COVID-19 response in the United States. Health Secur 19(1):65–74
Gülcan NY (2015) Discussing the importance of teaching ethics in education. Soc Behav Sci 174:2622–2625
Nelson T, Kagan N, Critchlow C, Hillard A, Hsu A (2020) The danger of misinformation in the COVID-19 crisis. Mo Med 117(6):510–512
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Bona, B.L. (2024). Future Medicine: Towards a More Conscious and Ethical Communication. In: Chiodo, S., Kaiser, D., Shah, J., Volonté, P. (eds) Improving Technology Through Ethics. SpringerBriefs in Applied Sciences and Technology(). Springer, Cham. https://doi.org/10.1007/978-3-031-52962-7_3
Download citation
DOI: https://doi.org/10.1007/978-3-031-52962-7_3
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-52961-0
Online ISBN: 978-3-031-52962-7
eBook Packages: Religion and PhilosophyPhilosophy and Religion (R0)